Further GO (Fig. 3c) and signaling pathway (Fig. 3d) analyses showed that the predicted targets of these miRNAs mainly focused on DNA binding, mitosis, integrated pancreatic cancer pathway, DNA damage response only ATM dependent, insulin signaling, and type II diabetes mellitus. Here, ATM is linked to familial pancreatic carcinoma.